CClinicalTrials.gg
CompletedNCT03314363MECCIASUpdated May 18, 2022

Plasma CO2 Removal Due to CRRT and Its Influence on Indirect Calorimetry

An interventional study of blood gas analysis under citrate predilution and filter replacement in Continuous Renal Replacement Therapy, CO2 Removal and Nutrition Poor, sponsored by Universitair Ziekenhuis Brussel. Completed at 1 site in Belgium. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-05-18.

Sponsored by Universitair Ziekenhuis Brussel · Not applicable, Interventional, and Diagnostic

Phase
Not applicable
Study type
Interventional
Enrollment
10
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

The aim of the present study is to assess the metabolic impact of Continuous Renal Replacement Therapy and overview the obstacles and important factors compromising the use of Indirect Calorimetry in CRRT and suggest a model to overcome these issues.

Read the detailed description

Acute kidney injury (AKI) complicates a critical illness from 13% up to 78%, needing renal replacement therapy (RRT) up to10 % of all patients in the intensive care unit (ICU). Both intermittent (IRRT) and continuous renal replacement therapy (CRRT) are used. The advantage of the latter is that it has lesser influence on hemodynamics and is better tolerated in critical ill patients.

Another complication during their stay is the inability to feed themselves. Nutrition is a cornerstone in the care for the critical ill and should be started within 3 days of admission to the intensive care unit. To optimize a nutritional prescription, protein and energy targets need to be defined. Predicting formulae based on anthropometric measures and other parameters can be used to calculate the caloric need but indirect calorimetry (IC) remains the gold standard. Caloric need can be derived from Energy expenditure which is calculated with the Weir's equation using carbon dioxide (CO2) production (VCO2) and oxygen (O2) consumption (VO2). Therefore, it is underestimated if CO2 is lost through other means than the normal respiratory route. Hence one of the contra-indications of IC is CRRT.

The totalCO2 (tCO2) travels through the vascular structures within the red blood cells or inside plasma. There, most of the content has 3 different forms: as physically dissolved CO2, bicarbonate, and carbamino compounds. These compounds are in equilibrium with each other. During RRT, a potential loss of CO2 and its different forms may occur due to ultrafiltration in the dialysate. No large trials were conducted trying to quantify this loss nor identifying the determining factors which can be used to predict this loss. Indeed, one author even found a gain in tCO2 of the blood during dialysis with acetate. Trisodiumcitrate is used as an anticoagulant during CRRT. It is a weak base and due to pH change may alter the equilibrium of the Henderson-Hasselbalch equation and thus influence the balance between CO2 and HCO3- and its extraction through CRRT.

Although indirect calorimetry in the intensive care unit has been evaluated during CRRT, the loss of tCO2was not considered. The investigators explored the possibility to predict and easily calculate this CO2 exchange so IC can be used during CRRT.

02

Conditions studied

  • Continuous Renal Replacement Therapy
  • CO2 Removal
  • Nutrition Poor
  • Acute Renal Failure

Keywords

  • Calorimetry, Indirect
  • respiratory dialysis
03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • AKI requiring CRRT
  • Patient on CRRT who's filter you want to change
  • Expected stable patient during the test ( +- 2h) evaluated at discretion of physician :

    • No alteration in medication
    • Stable respiratory settings where no change in conditions is expected. If possible, controlled mode ventilation is preferred.
    • Expected stable pH and lactate
    • no intervention will be made on patient (transport/washing/physiotherapy/...)
    • no alterations on settings of CRRT is expected to be made.
  • Maximal respiratory settings: max FiO2: 60% / max inspiratory plateau pressure 30 mmHg/max tidal volumes 8ml/kg
  • pH between 7,30-7,50, lactate levels \<2,0
  • starting settings CRRT with citrate:

    • Blood pump flow: 150 ml/min
    • Predilution ( citrate): 1500-2300ml/h
    • Dialysate dose: 25-40 ml/kg/h
    • ultrafiltration: 0-300 ml /h
    • Substitution: NaCl 300-800 ml/h or B22: 400-2000 ml/h

Exclusion criteria

Exclusion Criteria:

  • Pregnancy / lactation
  • Contra-indications for the use of indirect calorimetry as stated by the AARC (FiO2>60%, chest tubes)
  • Severe hemodynamic or ventilator instability.
  • CRRT modalities unusual to daily clinical ICU practice
04

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
10 participants (actual)

Study arms

  • Other
    all patients

    Classic CRRT with citrate predilution

    Diagnostic Test: blood gas analysis under citrate predilution · Device: filter replacement · Device: IC · Drug: NaCl predilution · Diagnostic Test: blood gas analysis under NaCl predilution · Drug: double ultrafiltration · Diagnostic Test: blood gas analysis under citrate predilution and double ultrafiltration rate · Dietary Supplement: pause and restart nutritional therapy · Diagnostic Test: evolution of vitamin and trace elements

Interventions

  • Diagnostic testblood gas analysis under citrate predilution

    blood gas analysis of blood on different sample points and dialysis fluid

  • Devicefilter replacement

    Using local protocol: stop and disconnect CRRT, replace filter and reconnect and restart CRRT.

  • DeviceIC

    monitor patients during the whole study period with indirect calorimetry

  • DrugNaCl predilution

    Replace citrate predilution with NaCl

  • Diagnostic testblood gas analysis under NaCl predilution

    repeat blood gas analysis of blood on different sample points and dialysis fluid

  • Drugdouble ultrafiltration

    double the ultrafiltration fluid by augmenting post dilution fluid and keeping ultrafiltration at the same rate.

  • Diagnostic testblood gas analysis under citrate predilution and double ultrafiltration rate

    repeat blood gas analysis of blood on different sample points and dialysis fluid

  • Dietary supplementpause and restart nutritional therapy

    pause parenteral and enteral nutrition before indirect calorimetry is performed. and restart after first blood analysis for vitamine status

  • Diagnostic testevolution of vitamin and trace elements

    blood analysis for vitamin and trace elements. Perform this blood analysis after restart of CRRT but before restart of nutritional therapy, 30 minutes after restart of nutritional therapy and 24h after restart of nutritional therapy.

05

What researchers measure

Primary outcomes

  1. change in CO2 flow and O2 flow on different sample points of CRRT

    CO2 flow and O2 flow ( ml/min) will be compared between the different sample points on CRRT with and without citrate. CO2 flow and O2 flow is calculated by multiplying fluid flow ( ml/min) on different sample points of CRRT with CO2 content or O2 content of fluid on respective sample points during CRRT with and without Citrate.

    Time frame: 2hours

  2. REE change due to CRRT

    REE ( Kcal) will be measured during the whole procedure using IC. REE will be measured during CRRT. citrate wil be replaced by NaCl 0,9% fluid and REE will be measured. After this, CRRT will be stopped and REE will be measured. The difference in REE during CRRT with and without citrate and without CRRT will be calculated and compared. REE is calculated using the weir equation and VO2, VCO2. VO2 and VCO2 is calculated using FiO2, FeO2, FiCO2, FeCO2 and VE.

    Time frame: 2hours

  3. does change in CO2 flow and O2 flow on different sample points of CRRT correlate with VCO2 and VO2 change due to CRRT with or without citrate

    VCO2 and VO2 change due to CRRT and due to citrate will be correlated with change in CO2 and O2 flow of fluids passing through CRRT with or without citrate.

    Time frame: 2 hours

  4. Are vitamins and trace elements sufficiently supplemented with standard nutritional therapy during CRRT

    blood analysis for concentrations of Vitamin A, B1, B6, B9, B12, C, D, E ; trace elements selenium, zinc, copper, chrome; and cholesterol and triglyceride

    Time frame: 24hours

Secondary outcomes

  1. VCO2 and VO2 change due to CRRT with or without citrate

    VCO2 and VO2 ( ml/min) will be measured during the whole procedure using IC. VCO2 and VO2 will be measured during CRRT with citrate. citrate wil be replaced by NaCl 0,9% fluid and VCO2 and VO2 will be measured. After this, CRRT will be stopped and VCO2 and VO2 will be measured. The difference in VCO2 and VO2 during CRRT with or without citrate and without CRRT will be calculated and compared. VO2 and VCO2 is calculated using FiO2, FeO2, FiCO2, FeCO2 and VE.

    Time frame: 2 hours

  2. FiO2, FeO2, FiCO2 and FeCO2 change due to CRRT with or without citrate

    FiO2, FeO2, FiCO2 and FeCO2 ( %) will be measured during the whole procedure using IC. FiO2, FeO2, FiCO2 and FeCO2 will be measured during CRRT with citrate. citrate wil be replace by NaCl0,9% fluid and FiO2, FeO2, FiCO2 and FeCO2 will be measured. After this CRRT will be stopped and FiO2, FeO2, FiCO2 and FeCO2 will be measured. The difference in FiO2, FeO2, FiCO2 and FeCO2 during CRRT with or without citrate and without CRRT will be calculated.

    Time frame: 2hours

  3. VE change due to CRRT with or without citrate

    VE( ml/min) will be measured during the whole procedure using IC. VE will be measured during CRRT with citrate. citrate wil be replace by NaCl0,9% fluid and VE will be measured. After this CRRT will be stopped and VE will be measured. The difference in VE during CRRT with or without citrate and without CRRT will be calculated.

    Time frame: 2hours

  4. change in CO2 and O2 content of fluid passing through CRRT

    using blood gas analyser, CO2 content and O2content ( mmol/L)of fluid on different sample points in extracorporeal circuit of CRRT with or without citrate will be analysed and compared.

    Time frame: 2hours

  5. change in bicarbonate content of fluid passing through CRRT

    using blood gas analyser, bicarbonate ( mmol/L) of fluid on different sample points in extracorporeal circuit of CRRT with or without citrate will be analysed and compared.

    Time frame: 2hours

  6. change in pH change of fluid passing through CRRT

    using blood gas analyser, pH of fluid on different sample points in extracorporeal circuit of CRRT with or without citrate will be analysed and compared

    Time frame: 2hours

  7. change in pCO2 and pO2 change of fluid passing through CRRT

    using blood gas analyser, pCO2 and pO2 (mmHg) of fluid on different sample points in extracorporeal circuit of CRRT with or without citrate will be analysed and compared.

    Time frame: 2hours

06

Study locations

1 site
  • universitair ziekenhuis Brussel
    Brussels, 1090, Belgium
07

References and documents

Publications

  • Case J, Khan S, Khalid R, Khan A. Epidemiology of acute kidney injury in the intensive care unit. Crit Care Res Pract. 2013;2013:479730. doi: 10.1155/2013/479730. Epub 2013 Mar 21. PubMed 23573420 ↗
  • Metnitz PG, Krenn CG, Steltzer H, Lang T, Ploder J, Lenz K, Le Gall JR, Druml W. Effect of acute renal failure requiring renal replacement therapy on outcome in critically ill patients. Crit Care Med. 2002 Sep;30(9):2051-8. doi: 10.1097/00003246-200209000-00016. PubMed 12352040 ↗
  • Rabindranath K, Adams J, Macleod AM, Muirhead N. Intermittent versus continuous renal replacement therapy for acute renal failure in adults. Cochrane Database Syst Rev. 2007 Jul 18;(3):CD003773. doi: 10.1002/14651858.CD003773.pub3. PubMed 17636735 ↗
  • Singer P, Berger MM, Van den Berghe G, Biolo G, Calder P, Forbes A, Griffiths R, Kreyman G, Leverve X, Pichard C, ESPEN. ESPEN Guidelines on Parenteral Nutrition: intensive care. Clin Nutr. 2009 Aug;28(4):387-400. doi: 10.1016/j.clnu.2009.04.024. Epub 2009 Jun 7. PubMed 19505748 ↗
  • Wichansawakun S, Meddings L, Alberda C, Robbins S, Gramlich L. Energy requirements and the use of predictive equations versus indirect calorimetry in critically ill patients. Appl Physiol Nutr Metab. 2015 Feb;40(2):207-10. doi: 10.1139/apnm-2014-0276. Epub 2014 Oct 27. PubMed 25610953 ↗
  • Oshima T, Berger MM, De Waele E, Guttormsen AB, Heidegger CP, Hiesmayr M, Singer P, Wernerman J, Pichard C. Indirect calorimetry in nutritional therapy. A position paper by the ICALIC study group. Clin Nutr. 2017 Jun;36(3):651-662. doi: 10.1016/j.clnu.2016.06.010. Epub 2016 Jun 22. PubMed 27373497 ↗
  • Honore PM, De Waele E, Jacobs R, Mattens S, Rose T, Joannes-Boyau O, De Regt J, Verfaillie L, Van Gorp V, Boer W, Collin V, Spapen HD. Nutritional and metabolic alterations during continuous renal replacement therapy. Blood Purif. 2013;35(4):279-84. doi: 10.1159/000350610. Epub 2013 May 8. PubMed 23689499 ↗
  • AARC clinical practice guideline. Metabolic measurement using indirect calorimetry during mechanical ventilation. American Association for Respiratory Care. Respir Care. 1994 Dec;39(12):1170-5. No abstract available. PubMed 10146137 ↗
  • Bosch JP, Glabman S, Moutoussis G, Belledonne M, von Albertini B, Kahn T. Carbon dioxide removal in acetate hemodialysis: effects on acid base balance. Kidney Int. 1984 May;25(5):830-7. doi: 10.1038/ki.1984.97. PubMed 6433099 ↗
  • Scheinkestel CD, Kar L, Marshall K, Bailey M, Davies A, Nyulasi I, Tuxen DV. Prospective randomized trial to assess caloric and protein needs of critically Ill, anuric, ventilated patients requiring continuous renal replacement therapy. Nutrition. 2003 Nov-Dec;19(11-12):909-16. doi: 10.1016/s0899-9007(03)00175-8. PubMed 14624937 ↗
  • Wu C, Wang X, Yu W, Li P, Liu S, Li J, Li N. Short-term consequences of continuous renal replacement therapy on body composition and metabolic status in sepsis. Asia Pac J Clin Nutr. 2016;25(2):300-7. doi: 10.6133/apjcn.2016.25.2.29. PubMed 27222413 ↗
  • Jonckheer J, Spapen H, Debain A, Demol J, Diltoer M, Costa O, Lanckmans K, Oshima T, Honore PM, Malbrain M, De Waele E. CO2 and O2 removal during continuous veno-venous hemofiltration: a pilot study. BMC Nephrol. 2019 Jun 17;20(1):222. doi: 10.1186/s12882-019-1378-y. Erratum In: BMC Nephrol. 2019 Aug 8;20(1):312. doi: 10.1186/s12882-019-1480-1. PubMed 31208356 ↗

Individual participant data

Plan to share: No

08

Registry details

Key details

Study ID
NCT03314363
Lead sponsor
Universitair Ziekenhuis Brussel
Responsible party
Elisabeth De Waele (Principal Investigator, clinical professor, Universitair Ziekenhuis Brussel) — Principal investigator
First posted
Oct 19, 2017
Start date
Apr 26, 2017
Primary completion
Mar 15, 2019
Completion
Mar 15, 2019
Last update
May 18, 2022

Study contacts

Elisabeth De Waele, Phd
principal investigator · Universitair Ziekenhuis Brussel

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion